From the laboratory to the clinic, IMB Dx aims to produce the most advanced liquid biopsy panel for the diagnostics
With sensitive LOD, IMB Dx is pioneering into a liquid biopsy and its translation into clinical tests in the global market
Innovation Begins with Robust Data. Our Innovative technology is enriched for rare ctDNA in the early stage of tumor of patient, making it an invaluable source for genomic targeting
Our technology can be applied to current tumor patient, high-risk person, and healthy person. IMB Dx aims to expand blood tests to detect cancer earlier on healthy person.
IMB Dx ㅣ What We Do ㅣ Product and Service ㅣ Customer Service ㅣ Careers
Address : 20F, Bldg A, BYC Highcity, 131, Gasan digital 1-ro, Geumcheon-gu, Seoul, 08506, Korea
Tel : +82-26951-2906 ㅣ Fax : +82-26947-3705 ㅣ E-mail : email@example.com
Copyright ⓒ IMB Dx, lnc. All rights reserved.